title: High-throughput identification of reference genes for research and clinical RT-qPCR analysis of breast cancer samples.
abstract: BACKGROUND
  Quantification and normalization of RT-qPCR data critically depends on the expression of so called reference genes. Our goal was to develop a strategy for the selection of reference genes that utilizes microarray data analysis and combines known approaches for gene stability evaluation and to select a set of appropriate reference genes for research and clinical analysis of breast samples with different receptor and cancer status using this strategy.
  
  
  METHODS
  A preliminary search of reference genes was based on high-throughput analysis of microarray datasets. The final selection and validation of the candidate genes were based on the RT-qPCR data analysis using several known methods for expression stability evaluation: comparative ∆Ct method, geNorm, NormFinder and Haller equivalence test.
  
  
  RESULTS
  A set of five reference genes was identified: ACTB, RPS23, HUWE1, EEF1A1 and SF3A1. The initial selection was based on the analysis of publically available well-annotated microarray datasets containing different breast cancers and normal breast epithelium from breast cancer patients and epithelium from cancer-free patients. The final selection and validation were performed using RT-qPCR data from 39 breast cancer biopsy samples. Three genes from the final set were identified by the means of microarray analysis and were novel in the context of breast cancer assay. We showed that the selected set of reference genes is more stable in comparison not only with individual genes, but also with a system of reference genes used in commercial OncotypeDX test.
  
  
  CONCLUSIONS
  A selection of reference genes for RT-qPCR can be efficiently performed by combining a preliminary search based on the high-throughput analysis of microarray datasets and final selection and validation based on the analysis of RT-qPCR data with a simultaneous examination of different expression stability measures. The identified set of reference genes proved to be less variable and thus potentially more efficient for research and clinical analysis of breast samples comparing to individual genes and the set of reference genes used in OncotypeDX assay.
authors.affiliation: SRC Bioclinicum, Moscow, Russia. d.maltseva@bioclinicum.com.
authors.forename: Diana V
authors.initials: DV
authors.lastname: Maltseva
authors.forename: Nadezda A
authors.initials: NA
authors.lastname: Khaustova
authors.forename: Nikita N
authors.initials: NN
authors.lastname: Fedotov
authors.forename: Elona O
authors.initials: EO
authors.lastname: Matveeva
authors.forename: Alexey E
authors.initials: AE
authors.lastname: Lebedev
authors.forename: Maxim U
authors.initials: MU
authors.lastname: Shkurnikov
authors.forename: Vladimir V
authors.initials: VV
authors.lastname: Galatenko
authors.forename: Udo
authors.initials: U
authors.lastname: Schumacher
authors.forename: Alexander G
authors.initials: AG
authors.lastname: Tonevitsky